Park Medi World Ltd. share price target

Update note - Capturing Growth in North India's Expanding Healthcare Landscape

We initiate coverage on Park Medi World (Park) with BUY and Mar-27E TP of Rs350 (37% upside), based on 21x Mar-28E EBITDA (in line with sector average). Park’s differentiated business model and lean cost structure allow it to deliver quality care at accessible prices.

IPO Note - Park Medi World Limited Park Medi World Limited is the second-largest private hospital chain in North India and the dominant player in Haryana, operating 14 NABH-accredited multi-super specialty hospitals with 3,250 beds as of September, 2025.

Company is the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and the largest private hospital chain in terms of bed capacity in Haryana with 1,600 beds located in the state as of March 31, 2025. Company operate a network of 14 NABH accredited multi-super specialty hospitals under the Park' brand, of which eight hospitals are also NABL accredited, with eight hospitals in...

About the Company: Park Medi is the second largest private hospital chain in North India with an aggregate bed capacity of ~3,250 beds, including 870 ICU beds, as well as 67 OTs and two dedicated cancer units. The Company operate a network of 14 multi-super specialty hospitals under the Park' brand. Park Medi has 8...

Park Medi World Ltd. (PMWL) ranks as the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds as of FY25. PMWL operates a network of 14 NABH accredited multi-super specialty hospitals under the Park' brand. It offers over 30 super specialty and specialty services including internal medicine, neurology, urology, gastroentereology general surgery, orthopedics and oncology. As of Sep'25, PMWL had a dedicated team of 1,014...